Kortuc
October 17, 2023
Franciscan B
Oncology
Company Description: A multi-indication, radiosensitizing platform to increase the effectiveness of radiotherapy and immunotherapy.
State
CA
Country
United States
Website
http://www.kortuc.com
CEO/Top Company Official
Kazu Matsuda
Lead Product in Development
KORTUC - a multi-indication, radiosensitizing platform to enhance the effectiveness of radiotherapy and immunotherapy. For Breast Cancer, we are in a Registraitional P2 study that began in 2020 and will finish in 2025E.
Development Phase of Primary Product
Phase II
Number Of Unlicensed Products
1
)
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
)
)